Bluefin Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-40,000
Closed -$1.83M 974
2021
Q4
$1.83M Hold
40,000
0.13% 137
2021
Q3
$1.19M Hold
40,000
0.12% 132
2021
Q2
$1.23M Hold
40,000
0.08% 163
2021
Q1
$770K Sell
40,000
-22,300
-36% -$1.13M 0.04% 226
2020
Q4
$652K Buy
+62,300
New +$2.01M 0.04% 246
2015
Q3
Sell
-110,100
Closed -$391K 598
2015
Q2
$391K Buy
+110,100
New +$5.62M 0.02% 327

Other funds holding THC

Bluefin Capital Management's THC Position: Q3 2022 in Review

Bluefin Capital Management sold out of Tenet Healthcare (THC) in Q3 2022, closing a stake of 16,338 shares — an estimated $924K sold.

Bluefin Capital Management first reported a position in THC in Q2 2017 and held it in 10 quarters. The position peaked at $32.2M in Q4 2021. 362 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Bluefin Capital Management reported no remaining Tenet Healthcare position as of Q3 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 16,338 Tenet Healthcare shares in Q3 2022, an estimated $924K.
  • Bluefin Capital Management first reported a position in Tenet Healthcare in Q2 2017 and held it in 10 quarters.
  • Bluefin Capital Management's Tenet Healthcare position peaked at $32.2M in Q4 2021.
  • 362 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Bluefin Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.